Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps

An evidence-based review with recommendations

David M. Poetker, Luke A. Jakubowski, Devyani Lal, Peter H. Hwang, Erin D. Wright, Timothy L. Smith

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background: Oral steroids are commonly used in the management of chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP, respectively). Past reports have included evaluation of the evidence for the use of oral steroids in CRS subtypes. However, a review with evidence-based recommendations for all CRS subtypes has never been performed. The purpose of this article is to provide a comprehensive, evidence-based approach for the utilization of oral steroids in the management of CRS. Methods: A systematic review of the literature was performed following recommendations of the Clinical Practice Guideline Manual, Conference on Guideline Standardization, and Appraisal of Guidelines and Research Evaluation. Inclusion criteria were: adult population ≥18 years old; CRS; oral steroids as the treatment group; and clearly defined primary clinical end-point. Results: This review identified and evaluated the literature on the use of oral steroids for CRSwNP, CRSsNP, allergic fungal sinusitis (AFS), and the use of oral steroids in the perioperative period in these patients. Recommendations based on evidence, benefit/harm assessment, and value judgments are made. Conclusion: Oral steroids are strongly recommended for short-term management of CRSwNP. Oral steroids are also recommended for management of AFS. Oral steroid use in CRSsNP is optional due to insufficient strong evidence. Oral steroids are also strongly recommended in the perioperative period for CRSwNP and AFS. There is no recommendation for oral steroids use in the perioperative period in patients with CRSsNP. The risks of oral steroids are rare, but significant adverse effects must be considered.

Original languageEnglish (US)
Pages (from-to)104-120
Number of pages17
JournalInternational Forum of Allergy and Rhinology
Volume3
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Nasal Polyps
Adrenal Cortex Hormones
Steroids
Perioperative Period
Sinusitis
Guidelines
Practice Guidelines

Keywords

  • Corticosteroids
  • Evidence-based-medicine
  • Nasal polyps
  • Rhinosinusitis
  • Sinusitis
  • Steroids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps : An evidence-based review with recommendations. / Poetker, David M.; Jakubowski, Luke A.; Lal, Devyani; Hwang, Peter H.; Wright, Erin D.; Smith, Timothy L.

In: International Forum of Allergy and Rhinology, Vol. 3, No. 2, 02.2013, p. 104-120.

Research output: Contribution to journalArticle

Poetker, David M. ; Jakubowski, Luke A. ; Lal, Devyani ; Hwang, Peter H. ; Wright, Erin D. ; Smith, Timothy L. / Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps : An evidence-based review with recommendations. In: International Forum of Allergy and Rhinology. 2013 ; Vol. 3, No. 2. pp. 104-120.
@article{1de463c6db8b4a2ca4e9e898d30315fd,
title = "Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: An evidence-based review with recommendations",
abstract = "Background: Oral steroids are commonly used in the management of chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP, respectively). Past reports have included evaluation of the evidence for the use of oral steroids in CRS subtypes. However, a review with evidence-based recommendations for all CRS subtypes has never been performed. The purpose of this article is to provide a comprehensive, evidence-based approach for the utilization of oral steroids in the management of CRS. Methods: A systematic review of the literature was performed following recommendations of the Clinical Practice Guideline Manual, Conference on Guideline Standardization, and Appraisal of Guidelines and Research Evaluation. Inclusion criteria were: adult population ≥18 years old; CRS; oral steroids as the treatment group; and clearly defined primary clinical end-point. Results: This review identified and evaluated the literature on the use of oral steroids for CRSwNP, CRSsNP, allergic fungal sinusitis (AFS), and the use of oral steroids in the perioperative period in these patients. Recommendations based on evidence, benefit/harm assessment, and value judgments are made. Conclusion: Oral steroids are strongly recommended for short-term management of CRSwNP. Oral steroids are also recommended for management of AFS. Oral steroid use in CRSsNP is optional due to insufficient strong evidence. Oral steroids are also strongly recommended in the perioperative period for CRSwNP and AFS. There is no recommendation for oral steroids use in the perioperative period in patients with CRSsNP. The risks of oral steroids are rare, but significant adverse effects must be considered.",
keywords = "Corticosteroids, Evidence-based-medicine, Nasal polyps, Rhinosinusitis, Sinusitis, Steroids",
author = "Poetker, {David M.} and Jakubowski, {Luke A.} and Devyani Lal and Hwang, {Peter H.} and Wright, {Erin D.} and Smith, {Timothy L.}",
year = "2013",
month = "2",
doi = "10.1002/alr.21072",
language = "English (US)",
volume = "3",
pages = "104--120",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps

T2 - An evidence-based review with recommendations

AU - Poetker, David M.

AU - Jakubowski, Luke A.

AU - Lal, Devyani

AU - Hwang, Peter H.

AU - Wright, Erin D.

AU - Smith, Timothy L.

PY - 2013/2

Y1 - 2013/2

N2 - Background: Oral steroids are commonly used in the management of chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP, respectively). Past reports have included evaluation of the evidence for the use of oral steroids in CRS subtypes. However, a review with evidence-based recommendations for all CRS subtypes has never been performed. The purpose of this article is to provide a comprehensive, evidence-based approach for the utilization of oral steroids in the management of CRS. Methods: A systematic review of the literature was performed following recommendations of the Clinical Practice Guideline Manual, Conference on Guideline Standardization, and Appraisal of Guidelines and Research Evaluation. Inclusion criteria were: adult population ≥18 years old; CRS; oral steroids as the treatment group; and clearly defined primary clinical end-point. Results: This review identified and evaluated the literature on the use of oral steroids for CRSwNP, CRSsNP, allergic fungal sinusitis (AFS), and the use of oral steroids in the perioperative period in these patients. Recommendations based on evidence, benefit/harm assessment, and value judgments are made. Conclusion: Oral steroids are strongly recommended for short-term management of CRSwNP. Oral steroids are also recommended for management of AFS. Oral steroid use in CRSsNP is optional due to insufficient strong evidence. Oral steroids are also strongly recommended in the perioperative period for CRSwNP and AFS. There is no recommendation for oral steroids use in the perioperative period in patients with CRSsNP. The risks of oral steroids are rare, but significant adverse effects must be considered.

AB - Background: Oral steroids are commonly used in the management of chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP, respectively). Past reports have included evaluation of the evidence for the use of oral steroids in CRS subtypes. However, a review with evidence-based recommendations for all CRS subtypes has never been performed. The purpose of this article is to provide a comprehensive, evidence-based approach for the utilization of oral steroids in the management of CRS. Methods: A systematic review of the literature was performed following recommendations of the Clinical Practice Guideline Manual, Conference on Guideline Standardization, and Appraisal of Guidelines and Research Evaluation. Inclusion criteria were: adult population ≥18 years old; CRS; oral steroids as the treatment group; and clearly defined primary clinical end-point. Results: This review identified and evaluated the literature on the use of oral steroids for CRSwNP, CRSsNP, allergic fungal sinusitis (AFS), and the use of oral steroids in the perioperative period in these patients. Recommendations based on evidence, benefit/harm assessment, and value judgments are made. Conclusion: Oral steroids are strongly recommended for short-term management of CRSwNP. Oral steroids are also recommended for management of AFS. Oral steroid use in CRSsNP is optional due to insufficient strong evidence. Oral steroids are also strongly recommended in the perioperative period for CRSwNP and AFS. There is no recommendation for oral steroids use in the perioperative period in patients with CRSsNP. The risks of oral steroids are rare, but significant adverse effects must be considered.

KW - Corticosteroids

KW - Evidence-based-medicine

KW - Nasal polyps

KW - Rhinosinusitis

KW - Sinusitis

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=84873906403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873906403&partnerID=8YFLogxK

U2 - 10.1002/alr.21072

DO - 10.1002/alr.21072

M3 - Article

VL - 3

SP - 104

EP - 120

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 2

ER -